339 related articles for article (PubMed ID: 34644471)
1. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
3. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
[TBL] [Abstract][Full Text] [Related]
4. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
5. Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B).
Spanos M; Chandrasekhar T; Kim SJ; Hamer RM; King BH; McDougle CJ; Sanders KB; Gregory SG; Kolevzon A; Veenstra-VanderWeele J; Sikich L
Contemp Clin Trials; 2020 Nov; 98():106103. PubMed ID: 32777383
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
[TBL] [Abstract][Full Text] [Related]
7. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
8. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
Owada K; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Yassin W; Kushima I; Benner S; Ogawa N; Kawano N; Eriguchi Y; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H; Yamasue H
Brain; 2019 Jul; 142(7):2127-2136. PubMed ID: 31096266
[TBL] [Abstract][Full Text] [Related]
9. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.
Fastman J; Foss-Feig J; Frank Y; Halpern D; Harony-Nicolas H; Layton C; Sandin S; Siper P; Tang L; Trelles P; Zweifach J; Buxbaum JD; Kolevzon A
Mol Autism; 2021 Sep; 12(1):62. PubMed ID: 34593045
[TBL] [Abstract][Full Text] [Related]
11. Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial.
Kong XJ; Liu J; Liu K; Koh M; Sherman H; Liu S; Tian R; Sukijthamapan P; Wang J; Fong M; Xu L; Clairmont C; Jeong MS; Li A; Lopes M; Hagan V; Dutton T; Chan SP; Lee H; Kendall A; Kwong K; Song Y
Nutrients; 2021 May; 13(5):. PubMed ID: 34062986
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
[TBL] [Abstract][Full Text] [Related]
13. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
[TBL] [Abstract][Full Text] [Related]
15. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
[TBL] [Abstract][Full Text] [Related]
16. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial.
Le J; Zhang L; Zhao W; Zhu S; Lan C; Kou J; Zhang Q; Zhang Y; Li Q; Chen Z; Fu M; Montag C; Zhang R; Yang W; Becker B; Kendrick KM
Psychother Psychosom; 2022; 91(5):335-347. PubMed ID: 35545057
[TBL] [Abstract][Full Text] [Related]
17. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
Hollander E; Jacob S; Jou R; McNamara N; Sikich L; Tobe R; Smith J; Sanders K; Squassante L; Murtagh L; Gleissl T; Wandel C; Veenstra-VanderWeele J
JAMA Psychiatry; 2022 Aug; 79(8):760-769. PubMed ID: 35793101
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.
Cai Q; Feng L; Yap KZ
Psychiatry Clin Neurosci; 2018 Mar; 72(3):140-151. PubMed ID: 29232031
[TBL] [Abstract][Full Text] [Related]
19. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Oxytocin for Obesity.
Plessow F; Kerem L; Wronski ML; Asanza E; O'Donoghue ML; Stanford FC; Eddy KT; Holmes TM; Misra M; Thomas JJ; Galbiati F; Muhammed M; Sella AC; Hauser K; Smith SE; Holman K; Gydus J; Aulinas A; Vangel M; Healy B; Kheterpal A; Torriani M; Holsen LM; Bredella MA; Lawson EA
NEJM Evid; 2024 May; 3(5):EVIDoa2300349. PubMed ID: 38815173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
